Moderate allcohol intake for even a short duration has deleterious effects on hematologic profile in Indian men .

Background: The damage that long-term alcohol abuse can do to the hematologic profile, is well documented; but, whether moderate alcohol intake for a short duration; alters hematologic profile or not, has not been established. Objective: In the present study, we examined hematologic profile in a group of short-term moderate alcohol drinkers and age and sex matched controls. Materials and Methods: The present cross sectional study was conducted in one of the tertiary care hospital. We recruited thirty young (20-40 years) men with history of daily 2 to 3 units of alcohol intake/day for the past 1 to 3 years duration. Another thirty age matched men, who were alcohol abstainers, served as controls. Two ml of blood was collected from anterior cubital vein after 12 hours of fasting. Hematological parameters were measured by using KX-21 Sysmex Automated Hematology Analyzer. Data were presented as means ± SD, and analysed using the one tailed unpaired (equal variance) ‘t’ test. The level of significance was taken at P values < 0.05. Results: We observed that the MCV value was significantly higher and platelet count was significantly lower in the moderate drinkers as compared to controls. Conclusion: Moderate alcohol intake for even a short duration has deleterious effects on hematologic profile in Indian men.

Hematologic Profiles and Eosinophilia in Very Low Birth Weight Infants / 대한주산의학회잡지

PURPOSE: This study investigated the pattern of hematologic profile and eosinophilia for a month after birth in very low birth weight (VLBW) infants. METHODS: The medical records of 141 VLBW infants (birth weight, or =700/mm3). RESULTS: Overall, 50.4% of all infants had at least one instance of eosinophilia for a month after birth. There were 50.7% with moderate eosinophilia (1,000-2,999/mm3). White blood cell (WBC) counts and absolute neutrophil count (ANC) climaxed on 7th day of life, whereas eosinophilia mainly occurred on 21st day of life. The demographic data and perinatal characteristics of infants with and without eosinophilia were compared. Prevalence of eosinophilia was associated with gestational age and total parenteral nutrition on 21st day of life; total parenteral nutrition and transfusion on 28th day of life. Eosinophilia was closely associated with transfusion on logistic regression analysis (P<0.05). CONCLUSION: Eosinophilia in VLBW infants occurs mainly on 21st day of life. Eosinophil counts showed a separate trend different from WBC counts and ANC. Transfusion was significantly associated with eosinophilia.

Avaliação do perfil hematológico de pacientes com leucemia linfocítica crônica (LLC-B) em um hemocentro estadual / Evaluation of the hematologic profile of patients with chronic lymphocytic leukemia (CLL-B) at a state hemocenter

Tem sido dada grande importância aos avanços na biologia molecular e genética no estabelecimento de novos protocolos, bem como à descoberta de novos marcadores tumorais, úteis ao diagnóstico e tratamento precoces de várias doenças neoplásicas, inclusive a leucemia linfocítica crônica de células B (LLC-B). Para avaliação da atual significância do sistema de estadiamento clínico de Rai no prognóstico de 50 pacientes com LLC-B em um hemocentro estadual, bem como para comparação entre os resultados do estadiamento com valores séricos de LDH e CD38 ao diagnóstico, foram coletados dos prontuários dos pacientes dados referentes à contagem total de linfócitos e plaquetas, concentração de hemoglobina, e também informações quanto à presença ou ausência de linfadenopatia e/ou organomegalia no período de admissão. Quando comparados os resultados do estadiamento com aqueles de outros estudos, observou-se uma situação preocupante quanto ao percentual superior de pacientes já classificados como de alto risco ao diagnóstico. Este quadro de aparente atraso na detecção da LLC-B foi em parte atribuído à dificuldade de acesso a centros especializados e/ou atraso na avaliação hematológica. Além disso, observaram-se incoerências entre os valores de LDH e CD38, e entre estes e o sistema de classificação clínica de Rai. Os resultados sugerem que este sistema de classificação pode ainda ser útil como panorama geral comparativo da LLC-B entre diferentes populações, mas também enfatizam a necessidade de modelos prognósticos específicos que considerem, além dos dados clínicos e marcadores CD38 e LDH, outros indicadores mais precisos do status mutacional IgVH para prognósticos e terapias mais exatos.

It has been given great importance to the advances in molecular biology and genetics in the establishment of new protocols, as well as to the discovery of new tumoral markers, useful to early diagnosis and treatment of various cancer diseases, inclusive B-cell Chronic Lymphocytic Leukemia (B-CLL). For evaluation of the actual significance of Rai clinical staging system in the prognosis of 50 B-CLL patients at a state hemocenter, as well as for comparison between the staging results with the serum values of LDH and CD38 at diagnosis, it was collected from patient promptuaries the data regarding the total lymphocyte and platelet counting, hemoglobin concentration, and also information about the presence or absence of linfadenopathy and/or organomegaly. When compared the staging results with those of other studies, it was noted a worrying situation considering the superior percentage of patients already classified as of high risk at diagnosis. This picture of apparent delay in the detection of CLL-B was to some extent attributed to the difficulty of access to specialized centers and/or delay in hematological evaluation. Additionally, it was observed some incoherence between LDH and CD38, and between these and the clinical classification system of Rai. The results suggest that this classification system may still be useful as a general comparative prospect of B-CLL between different populations, but also emphasize the requirement of specific prognostic models that consider, beyond the clinical data e the markers CD38 and LDH, other more precise indicatives of IgVH mutational status for more accurate prognosis and therapeutics.

Perinatal Outcome in Preterm Infants with Abnormal Umbilical Artery Doppler Results : Emphasizing on Early Onset Thrombocytopenia and its Risk Factors

PURPOSE:Umbilical artery Doppler study is a commonly used non-invasive tool in high risk pregnancies because of its good correlation with the degree of placental insufficiency. We analyzed hematologic profiles and perinatal outcome of preterm infants with abnormal umbilical artery Doppler results and the risk factors of early onset thrombocytopenia. METHODS:We retrospectively reviewed the medical records of preterm infants under 35 weeks of gestational age at birth who were admitted to the neonatal intensive care unit of Seoul National University Children's Hospital from January 1, 2002 through December 31, 2004, and whose mothers had undergone umbilical artery Doppler studies within 5 days before delivery. Sixty two neonates were divided into three groups; the 1st group was defined as the patients with normal umbilical artery (UA) systolic/diastolic (S/D) ratio, the 2nd group, with increased UA S/D ratio above 95 percentile, and the 3rd, with absent or reversed end-diastolic flow (AREDF). RESULTS:Mean nucleated red blood cell (nRBC) counts per 100 white blood cells (WBCs) were 14.2 (0-150), 91.0 (0-262), 301.4 (6-884) (P<0.001), mean WBC counts were 10.8 (0- 34.1), 9.2(3.4-23.9), 5.9(0.5-15.2) (x1,000/mm(3)) (P=0.007), and mean platelet counts were 215.5+/-69.2, 185.9+/-96.7, 100.2+/-50.3 (x1,000/mL) (